Navigation Links
PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Date:9/10/2009

SOUTH PLAINFIELD, N.J., Sept. 10 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of a Phase 3 trial of ataluren (formerly PTC124(R)), an investigational protein restoration therapy in patients with nonsense mutation cystic fibrosis (nmCF). Patients with CF lack adequate levels of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver, and other organs. In nmCF, an interruption in the genetic code -- known as a nonsense mutation -- prematurely halts the synthesis of CFTR, causing the protein to be short and non-functioning. Nonsense mutations are categorized as Class I mutations that result in little or no production of the CFTR protein. CF patients with Class I mutations typically experience more severe disease symptoms than those with low-risk genotypes, including a greater than twofold increased risk of death,(1) a higher probability of end-stage lung disease,(2) and a higher prevalence of pancreatic insufficiency.(2) Ataluren is designed to promote restoration of the missing CFTR. Through advances in genetic analysis, a simple test can now determine if a patient's disease is caused by a nonsense mutation.

(Logo:http://www.newscom.com/cgi-bin/prnh/20010919/PTCLOGO )

The primary objective of the registration-directed double-blind, placebo-controlled study is to evaluate whether ataluren can improve lung function, as measured by forced expiratory volume in one second (FEV1), in patients with nmCF. Other outcome measures will evaluate whether ataluren can reduce symptoms associated with nmCF, decrease lung infections, reduce the frequency of cough, and improve patient-reported quality of life. The 48-week trial is now enrolling patients at multiple resea
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up ... many of them wrote: "Take better care of my furry companion." ... designer clothes and top-brand carrying cases to take the little canine ... might also feel compelled to buy some pricey toys at the ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... company: time or money? , ,At the University of ... the time it takes to get products developed and produced ... end up with more you guessed it money. ... associate director of the center, said at a seminar Wednesday ...
... Charletta D. Flowers, right, who work for Milwaukee-based Johnson Controls, ... Energizer Battery Company in St. Louis. On Tuesday, August ... threw an elaborate party at Milwaukee's Pabst Theater ... a lot to be proud of. In the past year, ...
... Hansen. Source: Teresa Esser. Those who venture into the ... a huge black and white poster depicting Kelly Hansen as ... Comics, the full color version of the poster is located ... was ideal for the Marvel Comics-inspired Hall of Entrepreneurs because ...
Cached Biology Technology:University center offers speed boost to manufacturers 2Young Professionals of Milwaukee Celebrates Its Third Birthday, Looks To The Future 2Young Professionals of Milwaukee Celebrates Its Third Birthday, Looks To The Future 3Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 3
(Date:4/22/2014)... way of asking him or her to behave better. ... of the immune system tend to misbehave with age, ... cells are known to misbehave similarly during spaceflight, researchers ... to better understand how our immune systems change as ... Aging, part of the National Institutes of Health, have ...
(Date:4/22/2014)... MA, April 22, 2014 Researchers from NeuroPhage ... with the potential to treat most neurodegenerative diseases ... Alzheimer,s, Parkinson,s and Huntington,s diseases. These molecules are ... amyloid interaction motif, or GAIM, which recognizes a ... just one type of misfolded protein. This approach ...
(Date:4/21/2014)... brain research that can one day be applied to ... Khanh (Kate) Nguyen has been recognized as one of ... mathematics and physics, Nguyen is among the 2014 recipients ... of the most prestigious awards available to undergraduate students, ... students majoring in mathematics, the natural sciences or engineering ...
Breaking Biology News(10 mins):For an immune cell, microgravity mimics aging 2For an immune cell, microgravity mimics aging 3For an immune cell, microgravity mimics aging 4For an immune cell, microgravity mimics aging 5NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 2NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 3UH student named Goldwater Scholar, 2 more receive honorable mention 2UH student named Goldwater Scholar, 2 more receive honorable mention 3UH student named Goldwater Scholar, 2 more receive honorable mention 4
... Researchers from the Molecular Immunology group at the Helmholtz ... now shown that Beta-Interferon also plays a crucial role ... unable to show "wanted posters" of pathogens to other ... the pathogen and the immune response does not start ...
... size. Exhibiting novel and often surprising properties, they are finding ... In medical therapies, for example, tiny nanovehicles could one day ... only way of testing these approaches has been to wait ... a transported gene inside a cell for example. Under ...
... analysed which facial features our brain examines to identify faces. ... of information possible from each face and according to the ... first place, the eyes and then the shape of the ... by researcher Matthias S. Keil from the Basic Psychology Department ...
Cached Biology News:The right messenger for a healthy immune response 2Chasing tiny vehicles 2Chasing tiny vehicles 3Our brain looks at eyes first to identify a face 2Our brain looks at eyes first to identify a face 3
... TOPO Cloning is the ... for cloning PCR products. ... Zero Blunt TOPO vectors ... activated with topoisomerase I. ...
Applications: ISH...
... Clone/PAD: ZMD.420. Immunogen: Recombinant ... Specificity: Specific for the ~44 ... Reactivity: Human (positive control: IFN-Gamma-stimmulated ... on sequence homology reactivity with ...
...
Biology Products: